When will the FDA reclassify BPC-157 to Category 1?
When will the FDA reclassify BPC-157 to Category 1?
Chance
Before September
29%
Before September
29%
Before November
55%
Before November
55%
Before 2027
68%
Before 2027
68%
3 more
Market Rules
Before July
If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Jul 1, 2026, then the market resolves to Yes. Outcome verified from Food and Drug Administration.
- The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility.
- Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.
Timeline and payout
Market openMar 24, 2026 · 10:00am EDT
Market closesAfter the outcome occurs
Projected payout30 minutes after closing
SeriesKXFDAANNOUNCE
EventKXFDAANNOUNCE-BPC
MarketKXFDAANNOUNCE-BPC-26JUL01
Insider trading is prohibited
The following are prohibited from trading this contract:
- Persons who are employed by any of the Source Agencies are not permitted to trade on the Contract.
- Persons who hold any material, non-public information on the Underlying are not permitted to trade on the Contract.